INSIGHTS ON CLINICAL TRIAL DESIGN

• Overcoming Barriers To Clinical Trial Participation In Oncology

  Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.

• Direct-To-Patient Strategies Helping CRO Exceed Enrollment Targets

  This deep dive into a successful rescue mission of a Type 1 Diabetes clinical trial reveals how shifting to a direct-to-patient digital strategy can turn a failing timeline into a success story.

• How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?

  Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.

• Delivering A Registrational GI Trial Through Ongoing Protocol Shifts

  A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.

• Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study

  12/20/2024

  This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

• How To Build A Hybrid Visit Strategy That Delivers High-Quality Results

  7/11/2024

  In-home clinical trial visits yield major benefits for patients, including increased access and convenience. As a result, hybrid trials are helping developers increase enrollment, engagement, and retention.

• Applying AI to Study Simulation: From Design to Analysis

  5/12/2026

  See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

• Keeping Oncology Programs Moving As Complexity Increases

  5/1/2026

  As oncology trials grow more complex, speed depends on clarity. Consistent oversight and shared data help teams make confident decisions faster without losing control.

• Mastering Precision Oncology Start-Up: Reducing Screening Delays

  3/30/2026

  Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.